Notably, a few studies have shown a significant reduction in CCL22 levels during the acute phase of ischemic stroke in the circulation and infarct core, resulting in a higher National Institute of Health Stroke Scale (NIHSS)40. The gene discussed is CCL22; the disease is stroke disorder.